Flowtech Fluidpower – 103p

14 January 2010 – trading update

It is disappointing to report that the company has issued a profit warning for the year to 31 December 2019, with disappointing trading in the last quarter of the year having a negative impact on results.  Underlying pre-tax profit for the year is expected to be not less than £9.0m, a decline on last year’s £10.7m.  Expectations for 2020 have also been reviewed and although the group will benefit from investments made in 2019, the challenging trading conditions which are being experienced will make the first half of the year difficult.  Looking further ahead the company is well placed and the fall in the share price after today’s statement has probably been overdone.  The shares are a SPECULATIVE BUY.

Parity Group – 10.25p

14 January 2010 – trading update

The company has issued a positive trading update for the year to 31 December with results likely to be in line with expectations.  Strong cash collections in December mean that the group is likely to end the year with a positive net cash position as opposed to net debt of £1.1m at 31 December 2018.  We continue to rate the shares as a  BUY.

Personal Group – 360p

14 January 2020 – trading update

The company has confirmed that trading for the year to 31 December has been in line with expectations.  The company looks well placed to benefit from the continued growth and development of the employee services market and the attractive dividend yield of almost 6.5% will attract investors seeking income.  However, for those investors looking for growth there may be better opportunities elsewhere and following the recent spike in the share price now may be an opportune time to TAKE PROFITS.  

IndicoVision – 188p

13 January 2020 – trading update

The company has issued a trading update covering the year to 31 December and revealed that sales for the year were $50.1m, a 9% increase over the prior year.  Gross margins have been maintained at the same level as 2018 and helped by tight cost controls the company expects to report results in line with expectations.  The shares remain a BUY.

Surgical Innovations – 2.25p

13 January – trading statement

The company has issued a positive trading statement covering the year to 31 December stating that profits will be in line with expectations.  The second half of the year produced revenues that were 10% up on the first half whilst the lsast quarter of the year saw important contractual relationships extended.  Full year results will be announced towards the end of March and we maintain our recommendation of BUY.

 

cityconfidential © 2020 | T&Cs | Privacy | Wealth Warning